XML 47 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock compensation expense

The Company recorded the following Stock compensation expense in its consolidated statements of income (in thousands):

                         
    Years Ended December 31,
    2022   2021   2020
Stock option grants   $ 69       69       92  
Restricted stock awards     800       492       250  
Employee stock grant     50       50       530  
Annual director stock award     650       500       500  
Stock compensation   $ 1,569       1,111       1,372  
Summary of changes in outstanding options

A Summary of changes in outstanding options is presented below (in thousands, except share and per share amounts):

 

      Weighted   Weighted   Weighted
  Number   Average   Average   Average
  of   Exercise   Remaining   Grant Date
Options Shares   Price   Term (yrs)   Fair Value(000's)
Outstanding at                              
  January 1, 2020   132,504     $ 33.82       5.8     $ 1,631  
    Exercised   (12,415 )   $ 19.23             $ (100 )
Outstanding at                              
  December 31, 2020   120,089     $ 35.33       5.3     $ 1,531  
    Exercised   (15,334 )   $ 17.54             $ (115 )
Outstanding at                              
  December 31, 2021   104,755     $ 37.93       4.8     $ 1,416  
    Exercised   (16,460 )   $ 25.07             $ (145 )
Outstanding at                              
  December 31, 2022   88,295     $ 40.33       4.4     $ 1,271  
Exercisable at                              
  December 31, 2022   84,305     $ 40.07       4.3     $ 1,205  
Vested during                              
  twelve months ended                              
  December 31, 2022   4,179                     $ 69  
Stock options outstanding

The following table summarizes information concerning Stock options outstanding at December 31, 2022:

 

        Shares      Weighted     Weighted  
Range of Exercise       under     Average     Average  
Prices per Share       Option     Exercise Price   Remaining Life
                             
Non-exercisable:                            
$43.16 - $45.97       3,990       45.97       5.9  Years
                             
Exercisable:                            
$29.96 - $35.95       22,750         29.62       1.9  
$35.96 - $43.15       12,000         38.45       4.0  
$43.16 - $45.97       49,555         45.25       5.4  
        84,305       $ 40.07       4.3  Years
Total       88,295       $ 40.33       4.4  Years
Summary of changes in restricted stock awards

A Summary of changes in restricted stock awards is presented below (in thousands, except share and per share amounts):

 

        Weighted   Weighted   Weighted
    Number   Average   Average   Average
    Of   Exercise   Remaining   Grant Date
Restricted stock   Shares   Price   Term (yrs)   Fair Value(000's)
                 
Non-vested at January 1, 2020     0     $ 0         $ 0  
    Performance-based awards granted     20,520       46.30           950  
Non-vested at December 31, 2020     20,520     $ 46.30     3.4   $ 950  
    Time-based awards granted     8,896       45.55           405  
    Performance-based awards granted     18,882       45.55           860  
    Vested     (2,224 )     45.55           (101 )
Non-vested at December 31, 2021     46,074     $ 45.88     3.1   $ 2,114  
    Time-based awards granted     7,448       57.80           431  
    Performance-based awards granted     14,016       57.80           810  
    Vested     (15,679 )     47.56           (746 )
    Forfeited     (1,363 )     46.30           (63 )
Non-vested at December 31, 2022     50,496     $ 50.42     3.0   $ 2,546